In a filing, Neumora Therapeutics Inc revealed its Officer Henry Gosebruch acquired Company’s shares for reported $21450.0 on Mar 12 ’25. In the deal valued at $1.43 per share,15,000 shares were bought.
Then, BERNS PAUL L sold 13,871 shares, generating $23,468 in total proceeds. Upon selling the shares at $1.69, the insider now owns 7,405,004 shares.
Before that, Milligan Michael Lee sold 1,978 shares. Neumora Therapeutics Inc shares valued at $3,351 were divested by the insider at a price of $1.69 per share. As a result of the transaction, Milligan Michael Lee now holds 22,470 shares, worth roughly $26065.199999999997.
William Blair downgraded its Neumora Therapeutics Inc [NMRA] rating to a Mkt perform from a an Outperform in a research note published recently. A number of analysts have revised their coverage, including Stifel’s analysts, who decreased its forecast for the stock in early March from “a Buy” to “a Hold”. Guggenheim also remained covering NMRA and has decreased its forecast on March 07, 2025 with a “Neutral” recommendation from previously “Buy” rating. RBC Capital Mkts revised its rating on January 02, 2025. It rated NMRA as “a Sector perform” which previously was an “an Outperform”.
Price Performance Review of NMRA
On Tuesday, Neumora Therapeutics Inc [NASDAQ:NMRA] saw its stock fall -2.52% to $1.16. Over the last five days, the stock has lost -18.88%. Neumora Therapeutics Inc shares have fallen nearly -89.06% since the year began. Nevertheless, the stocks have fallen -92.33% over the past one year. While a 52-week high of $17.19 was reached on 01/07/25, a 52-week low of $1.16 was recorded on 03/18/25. SMA at 50 days reached $1.8138, while 200 days put it at $9.0410.
Levels Of Support And Resistance For NMRA Stock
The 24-hour chart illustrates a support level at 1.1200, which if violated will result in even more drops to 1.0800. On the upside, there is a resistance level at 1.2100. A further resistance level may holdings at 1.2600. The Relative Strength Index (RSI) on the 14-day chart is 24.42, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.1857, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 94.23%. Stochastics %K at 5.22% indicates the stock is a buying.
How much short interest is there in Neumora Therapeutics Inc?
A steep rise in short interest was recorded in Neumora Therapeutics Inc stocks on 2025-02-28, growing by 2.02 million shares to a total of 12.28 million shares. Yahoo Finance data shows the prior-month short interest on 2025-01-31 was 10.26 million shares. There was a rise of 16.47%, which implies that there is a positive sentiment for the stock.
